Wuhan Keqian Biology Co.,Ltd

¥11.64As of Sun 8 Nov 2026, 12:00 UTC
SSE:688526Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (13.62%)
Div yield 5.50%
ROE 5.45%
Biotechnology
Beta (5Y) 0.40
PE TTM 23.93
TSR TTM (24.71%)
Mkt cap ¥5.400B
ROIC 8.28%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥15
25.32%
(54.68%)
Hold 9|7|7|3|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.16
0.17
0.16
0.18
37.38%
42.83%
23.81%
25.42%
Revenue¥M
304.0
302.8
319.6
314.1
11.73%
11.58%
15.62%
8.06%
Peers (US$809.5M)
Cap (US$)
PE
822.8M
197.9x
807.2M
496.4x
Capital
TTM
5Y
10Y
Leveragex
0.588
(0.102)
(0.108)
EBIT/Intx
0.538
0.280
0.302
Own earn%
(101.14)
20.46
27.98
Sh yield%
58.24
40.21
35.31
Owners
Insiders/Inst%
12.60
32.03
Short interest%
4.88
SBC / revenue%
5.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
24–32
$1 testx
0.0
Incr. ROIC%
0